Click on a tag to filter your results:
vaccineshealth
COVID-19
infants
virus infection
northern community
physical health
immune response
2 record(s) found in the location "" (multi-year projects are grouped):
Not seeing the results you want? Tryadvanced search.
COVID-19 vaccination effectiveness in Indigenous peoples in the Northwest Territories
Principal Investigator: Sharma, Sangita
Licensed Year(s): 2024 2023
Summary: This licence has been issued for the scientific research application No. 5762. In four Northwest Territories communities, the researchers aim to determine the immune response to COVID-19 vaccines and how long this protection lasts in Indigenous community members. In partnership with the Tli?cho Government, the researchers aim to determine COVID-19 immune protection (immunity) among communit...
Licensed Year(s): 2024 2023
Summary: This licence has been issued for the scientific research application No. 5762. In four Northwest Territories communities, the researchers aim to determine the immune response to COVID-19 vaccines and how long this protection lasts in Indigenous community members. In partnership with the Tli?cho Government, the researchers aim to determine COVID-19 immune protection (immunity) among communit...
Haemophilus Influenzae type B Meningitis Control Project in the Northwest Territories.
Principal Investigator: Barreto, Luis
Licensed Year(s): 1987
Summary: A preliminary study will be undertaken to confirm the safety and the immunogenicity of the Connaught conjugate vaccine for native populations of the NWT (Phase I). This will be determined by the frequency and severity of adverse responses to three doses of the vaccine by a sample of infants 2-3 months of age drawn from Inuit and Dene populations. Parental consent will be obtained for all those in...
Licensed Year(s): 1987
Summary: A preliminary study will be undertaken to confirm the safety and the immunogenicity of the Connaught conjugate vaccine for native populations of the NWT (Phase I). This will be determined by the frequency and severity of adverse responses to three doses of the vaccine by a sample of infants 2-3 months of age drawn from Inuit and Dene populations. Parental consent will be obtained for all those in...
TOTAL PAGES: 1
